John A. Merenich, MD

home / authors / john-a-merenich-md

Articles

February 26th 2014

Positive Predictive Values of ICD-9 Codes to Identify Patients With Stroke or TIA

Kari L. Olson, BSc(Pharm), PharmD Michele D. Wood, PharmD Thomas Delate, PhD Lisa J. Lash, PharmD Jon Rasmussen, PharmD Anne M. Denham, PharmD John A. Merenich, MD

This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.

August 7th 2009

Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management

Kari L. Olson, PharmD Thomas Delate, PhD Jon Rasmussen, PharmD Tammy L. Humphries, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group

Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.

October 1st 2007

Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus

Karen J. McConnell, PharmD Emily B. Zadvorny, PharmD Anne M. Denham, PharmD Sheila L. Kasten, PharmD Kara A. Hutka, PharmD Cedar R. Koetting, PharmD John A. Merenich, MD for the Clinical Pharmacy Cardiac Risk Service Study Group

June 1st 2004

The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) Study: Evaluating the Role of Drug Therapy Within a Weight Management Program in a Group-Model Health Maintenance Organizati

Julie A. Porter, PharmD Marsha A. Raebel, PharmD Douglas A. Conner, PhD Frances A. Lanty, PharmD Erin A. Vogel, PharmD Elizabeth C. Gay, MA John A. Merenich, MD